Youngsoo Kim

4.2k total citations · 2 hit papers
38 papers, 2.9k citations indexed

About

Youngsoo Kim is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Youngsoo Kim has authored 38 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Hematology. Recurrent topics in Youngsoo Kim's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and RNA Research and Splicing (6 papers). Youngsoo Kim is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and RNA Research and Splicing (6 papers). Youngsoo Kim collaborates with scholars based in United States, South Korea and China. Youngsoo Kim's co-authors include A. Robert MacLeod, David L. Spector, Gayatri Arun, Jeff Hsu, Gene Hung, Moritz F. Eissmann, Alexey S. Revenko, Matthias Groß, Martin Zörnig and Tony Gutschner and has published in prestigious journals such as Nature Communications, Genes & Development and Blood.

In The Last Decade

Youngsoo Kim

37 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells

2012 1.3k citations Tony Gutschner, Monika Hämmerle et al. Cancer Research profile →
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss

2015 468 citations Gayatri Arun, Youngsoo Kim et al. profile →

Peers

Countries citing papers authored by Youngsoo Kim

Since Specialization

Citations

This map shows the geographic impact of Youngsoo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngsoo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngsoo Kim more than expected).

Fields of papers citing papers by Youngsoo Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngsoo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngsoo Kim. The network helps show where Youngsoo Kim may publish in the future.

Co-authorship network of co-authors of Youngsoo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Youngsoo Kim. A scholar is included among the top collaborators of Youngsoo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngsoo Kim. Youngsoo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption 2021 ·Cell stem cell ·(unknown), (unknown), Tianyuan Zhou, Elisa Lazzari, Luisa Ladel, Xiaolin Luo, Youngsoo Kim, Caitlin Costello, A. Robert MacLeod, Catriona Jamieson, Leslie Crews	38
2	Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth 2021 ·iScience ·(unknown), Marina Koukaki, (unknown), Antonis Giakountis, Elena Deligianni, Xiaolin Luo, Youngsoo Kim, Iannis Talianidis	8
3	Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas^lpr mice 2020 ·Theranostics ·Hong Kyung Lee, Hyung Sook Kim, (unknown), Eun Jae Park, (unknown), (unknown), (unknown), Kyung Suk Kim, Sang‐Cheol Bae, Youngsoo Kim, Jin Tae Hong, Jaesuk Yun, Sang‐Bae Han	17
4	Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma 2020 ·Retrovirology ·Daniel A. Rauch, Sydney L. Olson, John C. S. Harding, (unknown), Youngsoo Kim, Tianyuan Zhou, A. Robert MacLeod, Grant A. Challen, Lee Ratner	9
5	An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma 2019 ·Cancer Research ·Shili Xu, Tianyuan Zhou, (unknown), K. Ryan Trinh, (unknown), Jason T. Lee, Daniel Braas, Nicholas Bayley, Reiko Yamada, (unknown), Joshua Sasine, John M. Timmerman, Sarah M. Larson, Youngsoo Kim, A. Robert MacLeod, Sherie L. Morrison, Harvey R. Herschman	44
6	Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models 2019 ·Molecular Therapy ·Youngsoo Kim, Minji Jo, Joanna Schmidt, Xiaolin Luo, Thazha P. Prakash, Tianyuan Zhou, Stéphanie Klein, Xiaokun Xiao, Noah Post, Zhengfeng Yin, A. Robert MacLeod	49
7	Therapeutic Targeting of Interferon Regulatory Factor 4 with Next Generation Antisense Oligonucleotides Produces Robust In Vivo Antitumor Activity in Preclinical Models of Multiple Myeloma 2017 ·Blood ·Tianyuan Zhou, Joanna Schmidt, Youngsoo Kim, A. Robert MacLeod	3
8	Strong pharmacological activity of locally administered next-generation antisense oligonucleotides (ASOs) in orthotopic lung cancer mouse models 2016 ·Journal of Thoracic Oncology ·Minji Jo, Joanna Schmidt, Tianyuan Zhou, Xuefeng Wu, Jeffrey R. Crosby, Emily Brand, Youngsoo Kim, A. Robert MacLeod	1
9	Phlorizin, an Active Ingredient of Eleutherococcus senticosus, Increases Proliferative Potential of Keratinocytes with Inhibition of MiR135b and Increased Expression of Type IV Collagen 2016 ·Oxidative Medicine and Cellular Longevity ·Hye‐Ryung Choi, (unknown), Hyun-Sun Lee, (unknown), Youngsoo Kim, Jongsung Lee, (unknown), (unknown), Kyoung‐Chan Park	16
10	Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth 2015 ·Clinical Cancer Research ·Yoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, Fan Zhang, Alexander W. Wyatt, Nader Al Nakouzi, Fan Mo, Tianyuan Zhou, Youngsoo Kim, Brett P. Monia, A. Robert MacLeod, Ladan Fazli, Yuzhuo Wang, Colin C. Collins, Amina Zoubeidi, Martin Gleave	105
11	The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells breakdown → 2012 ·Cancer Research ·Tony Gutschner, Monika Hämmerle, Moritz F. Eissmann, Jeff Hsu, Youngsoo Kim, Gene Hung, Alexey S. Revenko, Gayatri Arun, Marion Stentrup, Matthias Groß, Martin Zörnig, A. Robert MacLeod, David L. Spector, Sven Diederichs	1307
12	The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism 2012 ·PLoS ONE ·Xin Zheng, Natalia Belén Rumie Vittar, Xiaohong Gai, Maite G. Fernández‐Barrena, Catherine D. Moser, Chunling Hu, Luciana L. Almada, Angela L. McCleary‐Wheeler, Sherine F. Elsawa, Anne M. Vrabel, Abdirashid M. Shire, Andrea Comba, Snorri S. Thorgeirsson, Youngsoo Kim, Qingguang Liu, Martín E. Fernández-Zapico, Lewis R. Roberts	63
13	A Case of Digital Gangrene Complicated by Atypical Hemolytic Uremic Syndrome in a Patient with Systemic Lupus Erythematosus 2010 ·Kidney Research and Clinical Practice ·(unknown), (unknown), (unknown), Youngsoo Kim, Young‐Ok Kim, (unknown)	2
14	Conditional β-Catenin Loss in Mice Promotes Chemical Hepatocarcinogenesis: Role of Oxidative Stress and Platelet-Derived Growth Factor Receptor α/Phosphoinositide 3-Kinase Signaling† 2010 ·Hepatology ·Xu‐Feng Zhang, Xinping Tan, Gang Zeng, (unknown), Sucha Singh, Youngsoo Kim, James E. Klaunig, Satdarshan P. Monga	76
15	Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells 2007 ·Cancer Research ·Youngsoo Kim, Joon Won Yoon, Xiaokun Xiao, Nicholas M. Dean, Brett P. Monia, Eric G. Marcusson	91
16	Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia 2007 ·Anti-Cancer Drugs ·(unknown), Eun-Kyung Bae, Young Ju Kim, Kwang-Sung Ahn, (unknown), Jiyoung Rhee, Young Yiul Lee, Youngsoo Kim, (unknown), Byoung Kook Kim, Sung‐Soo Yoon	6
17	Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3 2006 ·Clinical Cancer Research ·(unknown), Sheng‐Long Ye, Ruixia Sun, Yinkun Liu, Zhao–You Tang, Youngsoo Kim, James G. Karras, Hong Zhang	118
18	Identification of novel PPARγ target genes in primary human adipocytes 2005 ·Gene ·Ranjan J. Perera, Eric G. Marcusson, Seongjoon Koo, Xiaolin Kang, Youngsoo Kim, Neill White, Nicholas M. Dean	55
19	Identification of Differentially Expressed Proteins in Imatinib Mesylate-resistant Chronic Myelogenous Cells 2005 ·BMB Reports ·Jungeun Park, Sangmi Kim, (unknown), (unknown), (unknown), (unknown), Youngsoo Kim	12
20	Construction of Metallothionein-I Promoter Inserted Human Blood Coagulation Factor VIII Expression Vector and the Induction of Factor VIII Protein Synthesis in Mouse 1995 ·Experimental & Molecular Medicine ·(unknown), Seok-Hyun Kim, Yoo Hong Min, Youngsoo Kim, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact